Vascular located monocytes/macrophages engulf oxidized-LDL (ox-LDL), generating foam cells which release a plethora of pro-inflammatory mediators
Structural, enzymatic and pharmacological profiles of AplTX-II a basic sPLA2 (D49) isolated from the Agkistrodon piscivorus leucostoma snake venom
If you are on a gradually increasing schedule, you might find that your vial lasts longer in the beginning when the dose is lower, but it will be used up faster as your dosage increases
Several non-insulin-based therapies are available for the management of T2D, including metformin, sulfonylureas, thiazolidinediones, dipeptidyl peptidase 4 inhibitors (DPP-4i), sodium-glucose co-transport-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), amylin analogues, and alpha-glucosidase inhibitors